Headaches from Semaglutide: Separating Fact from Worry

Headaches appear in clinical trial data for semaglutide (Wegovy) and are most commonly linked to reduced food and fluid intake rather than a direct drug effect on the brain.
They tend to be mild-to-moderate and most noticeable in the first weeks of treatment or after a dose step, often settling on their own.
Severe or sudden-onset headache, or headache accompanied by visual changes or confusion, warrants prompt medical attention — these are not typical semaglutide headaches.
Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme, you do not need your prescriber to do this for you.

Headaches are a recognised side effect of semaglutide, reported by a meaningful proportion of people in clinical trials — but they are rarely the whole story, and they rarely last. If you've started Wegovy and noticed a dull ache behind your eyes or a tension headache that wasn't there before, you're not imagining it. These medicines work partly by slowing gastric emptying and suppressing appetite, which changes how much you eat and drink; that shift alone can trigger headaches in the early weeks. They are a prescription-only medicine requiring clinical assessment before any treatment begins, and our prescribers walk through side effects like this as part of every consultation at nume.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and clinical experience actually tell us about semaglutide headaches

The biggest misconception: most people assume the headache is the drug acting on the brain

The instinctive assumption when a new medicine causes a headache is that the drug is doing something neurological. With semaglutide, that's usually not what's happening. The more common culprits are indirect: eating considerably less than before, drinking less fluid because you feel full, and the body adjusting to a new metabolic rhythm. GLP-1 receptor agonists slow stomach emptying significantly, so both calories and hydration can drop sharply in the first weeks, conditions that reliably produce headaches in almost anyone, medicine or not.

The NHS medicines information for semaglutide lists headache as a common side effect, meaning it affects between 1 in 10 and 1 in 100 people. That's common enough to be worth knowing about, not so common that it defines the experience. Most people who do get headaches on Wegovy describe them as tension-type, low-grade, and time-limited, peaking in the first week or two and fading as eating and drinking patterns stabilise, and if you want to understand how Wegovy and headaches tend to relate across that early period, the picture becomes clearer when you look at what's actually driving them. If you want a fuller picture of how quickly the body begins to adjust, our page on the semaglutide side-effect timeline maps the typical arc from week one onwards.

Practical measures matter here. Staying well hydrated (more than you think you need when nausea is suppressing your thirst) and maintaining regular, protein-adequate meals (even small ones) removes the most common triggers. That's not a workaround; it's just physiology.

When headaches after a dose increase are a different conversation

Wegovy's escalation schedule moves from 0.25mg through 0.5mg, 1.0mg and 1.7mg up to a 2.4mg maintenance dose, with each step typically taken around four weeks apart. Headaches can resurface at each step for the same indirect reasons: the appetite-suppressing effect intensifies, intake drops again, and the body recalibrates. If you're wondering whether Wegovy causes headaches or whether something else is going on, the dose-escalation pattern is usually a good place to start looking for an explanation.

The distinction to hold in mind is between a familiar tension headache that responds to hydration and rest, and a headache that's new in character, notably different in location, severity or the way it came on. A sudden, severe headache that feels unlike any you've had before is not a semaglutide adjustment headache; it needs same-day medical attention regardless of what medicines you're taking.

Our overview of Wegovy side effects puts headache in context alongside the more frequently discussed gastrointestinal symptoms, nausea, constipation and reflux get most of the attention, but headache often catches people off guard because it feels unrelated to a weight-loss medicine. It's a reasonable thing to raise with your prescriber at any point. At nume, clinical review doesn't stop after the first pen arrives; aftercare is built in, seven days a week.

When to get medical help, and what headache signals aren't typical

This is the part that deserves plain language. Most semaglutide headaches don't need a GP call. They need water, food and a little time. But some do.

Seek prompt medical attention if you experience: a headache that is sudden and severe (sometimes described as the worst of your life); headache with visual disturbance, slurred speech or facial drooping; headache alongside signs of severe dehydration, dark urine, dizziness on standing, rapid heart rate from repeated vomiting or diarrhoea; or persistent headache that doesn't respond to over-the-counter analgesia and is getting worse over days.

The MHRA's January 2026 Drug Safety Update on GLP-1 medicines also flags acute pancreatitis as a separate serious side effect to be aware of: severe stomach pain that radiates to the back, with or without vomiting, is the key symptom, not a headache, but worth knowing if you're reading up on safety. Our page covering semaglutide headache in detail is a useful reference if you want to separate the expected from the symptoms that genuinely warrant a call. You can report any unexpected side effect through the Yellow Card scheme, which is how post-market safety signals get identified and acted on. Your report matters.

If you're uncertain whether your symptoms are typical, the honest answer is: contact your prescriber. Our support team is available seven days a week for exactly this kind of question.

Starting Wegovy: what a clinically supervised route looks like in practice

Wegovy is a prescription-only medicine. Getting it through a GPhC-registered pharmacy means a real clinician has reviewed your health history before a single pen is dispensed, not software making a binary decision, but a qualified prescriber reading your answers and deciding whether treatment is appropriate for you, including flagging anything in your profile that might affect how side effects land.

At nume, a GPhC-registered Independent Prescriber reviews every consultation the same day it's submitted. If you order before noon on a working day and your prescription is approved, your treatment is dispatched that afternoon through DPD, tracked to your door the next working day, in plain unbranded packaging. The pen itself is a pre-filled device; no mixing, no measuring. It comes with a patient information leaflet that covers every side effect in detail, and our prescribers are the right people to call if something in those pages concerns you.

If you're weighing up whether Wegovy is right for your situation, our Wegovy overview covers the full picture, licence, eligibility, evidence and how private treatment works. And if you'd like to explore all available weight-loss treatment options before deciding, that's a reasonable place to start too. Check your eligibility whenever you're ready, there's no commitment in the consultation itself.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions